Loading data
CHGANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 1.33 m USD | 1.26 m USD | 1.2 m USD | 1.39 m USD |
| Gross profit | — | — | — | 272.73 k USD | 414.52 k USD |
| Research and development expense | — | — | 109.62 k USD | 731.33 k USD | 1.03 m USD |
| Operating profit | -7.59 m USD | -4.84 m USD | -15.75 m USD | -8.79 m USD | -8.83 m USD |
| Interest expense | — | — | — | 176 k USD | — |
| Profit before tax | -17.52 m USD | -7.04 m USD | -16.71 m USD | -11.93 m USD | -9.09 m USD |
| Net income (reported basis) | -18.26 m USD | -7.9 m USD | -16.71 m USD | -11.93 m USD | -9.09 m USD |
| Net income attributable to common shareholders | -18.1 m USD | -7.9 m USD | -16.71 m USD | -11.93 m USD | 60.46 k USD |
| Basic earnings per share | -112.74 USD/share | -168.76 USD/share | -23.8 USD/share | -1.28 USD/share | -1.07 USD/share |
| Diluted earnings per share | -112.74 USD/share | -168.76 USD/share | -23.8 USD/share | -1.28 USD/share | -1.07 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.